The Valley Desk

NCT01602406 · Interventional trial

Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer

Overall registry status Completed

Phase 1

Conditions Advanced HER2-positive Breast Cancer or Gastric Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov